Medicine and Dentistry
Systematic Review
100%
Adolescence
60%
Body Mass Index
50%
Meta-Analysis
43%
Quality of Life
36%
Adverse Event
32%
Anti-Obesity Medication
30%
Disease Course
22%
Multiple Chronic Conditions
20%
Human Milk
20%
Network Meta-Analysis
20%
Lyme Borreliosis
20%
Surgery
20%
Placenta
20%
Gas Exchange
20%
Infection
20%
COVID-19
20%
Mental Health
20%
Volumetry
20%
Congenital Anomalies of the Kidney and Urinary Tract
20%
Cardiometabolic Risk
20%
Mental Disorder
20%
Lung
20%
Body Fat Percentage
20%
Serositis
20%
Insulin Dependent Diabetes Mellitus
20%
Neonatal Intensive Care Unit
20%
Antibiotics
16%
Diabetic Ketoacidosis
16%
Pod
16%
Gestational Age
13%
Prematurity
12%
Placebo
10%
Randomized Controlled Trial
10%
Hypoglycemia
10%
Health Behavior
10%
Diabetes
10%
Hemoglobin A1c
10%
Childhood Obesity
10%
Comorbidity
9%
Semaglutide
8%
Anxiety Disorder
8%
Prospective Study
8%
Depression
8%
Health Outcomes
8%
Oxygenator
8%
Conservative Treatment
6%
Study Participant
6%
Controlled Clinical Trial
6%
Forest Plot
6%
Injury
6%
Clinical Finding
6%
Radiological Finding
6%
Drug Therapy
6%
Insulin Pump
6%
Respiratory Distress
6%
Kawasaki Disease
6%
Dyslipidemia
5%
Hypertension
5%
Glucose Metabolism
5%
Phentermine/Topiramate
5%
Minority Group
5%
Obesity Management
5%
Public Health
5%
Bariatric Surgery
5%
Recurrent Disease
5%
Nursing and Health Professions
Meta Analysis
40%
Systematic Review
40%
Drug Therapy
36%
Body Mass
33%
Adolescent
26%
Adverse Event
26%
Reproducibility
20%
Fat Free Mass
20%
Plethysmography
20%
Body Composition
20%
Neonatal Intensive Care Unit
20%
Mental Health
20%
Disease
20%
Inflammation
20%
Infection
20%
Body Weight
15%
Confidence Interval
13%
Childhood Obesity
13%
Semaglutide
10%
Quality of Life
6%
Newborn Intensive Care
6%
Data Extraction
6%
Bariatric Surgery
6%
Minority Group
6%
Obesity Management
6%
Phentermine/Topiramate
6%
Narrative Method
6%
Drug Development
6%
Recurrent Disease
6%
Prematurity
6%
Nutrition Policy
6%
Maximum Permissible Dose
6%
Nursing Care
6%
Healthcare System
6%
Mucocutaneous Lymph Node Syndrome
5%
Severe Acute Respiratory Syndrome
5%
Clinical Practice
5%
Fat Mass
5%
Assisted Ventilation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
30%
Disease
25%
Disease Course
21%
Childhood Obesity
20%
Lyme Disease
20%
Multiple Chronic Conditions
20%
Infection
20%
Obesity
20%
Insulin Dependent Diabetes Mellitus
20%
Hemoglobin A1c
20%
Inflammation
20%
Cohort Study
20%
Diabetic Ketoacidosis
16%
Antibiotics
16%
Hypertransaminasemia
12%
Randomized Controlled Trial
11%
Placebo
10%
Hypoglycemia
10%
Premature Labor
10%
Comorbidity
10%
Anxiety Disorder
5%
Mucocutaneous Lymph Node Syndrome
5%
Small for Date Infant
5%
High Density Lipoprotein Cholesterol
5%
Elevated Blood Pressure
5%
Semaglutide
5%
Glycosylated Hemoglobin
5%